secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOADAPTIVES, INC. (BDPT)
CIK:        0001575142
Form:       8-K
Filed at:   2021-12-16T23:59:59+00:00
Accession:  0001640334-21-003192
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAdaptives enters marketing agreement for LungFlute medical device; plans LungArmor package
--------------------------------------------------------------------------------

- Marketing agreement with Acoustic Innovations LLC for LungFlute™ OscPEP device; rights in US, Canada, and other approved regions.
- Device is FDA-cleared, creates low-frequency acoustic energy to loosen mucus; used in $800K TB trial in Africa.
- BioAdaptives to market device as LungCleanser™ combined with PrimiLungs™ supplement as LungArmor™ package.
- No financial terms of the agreement disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1575142/000164033421003192/0001640334-21-003192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1575142/000164033421003192/bdpt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-21-003192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer